?????????????????????????? ??????????????????????????102 On the flip side, many teams are advocating to the incorporation of novel markers, such as a intricate karyotype55 or epigenetic subsets, 27,28 into clinical follow. Every one of these novel prognostic and/or predictive types will must be validated in cohorts of people dealt with with specifi